US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Seaport Therapeutics

23.68

-0.3600-1.50%

Post-market: 23.680.00000.00%16:10 EDT

Volume:117.84K

Turnover:2.80M

Market Cap:1.27B

PE:-9.41

High:26.47

Open:24.14

Low:23.01

Close:24.04

52wk High:28.38

52wk Low:14.85

Shares:53.53M

Float Shares:14.16M

Volume Ratio:0.97

T/O Rate:0.83%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5160

EPS(LYR):-10.0430

ROE:-28.08%

ROA:-18.90%

PB:3.00

PE(LYR):-2.36

Loading ...

Overview Company News Filings

Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss

MT Newswires Live

Seaport Therapeutics - Q1 Net Loss per Share $10.34

THOMSON REUTERS

Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

THOMSON REUTERS

Seaport Therapeutics - Seven-Day Glyphago Dosing Achieves Therapeutic Agomelatine Exposures Without Liver Enzyme Elevations

THOMSON REUTERS

Seaport Therapeutics - to Initiate Phase 2B Glyphago Trial in First Half of 2027

THOMSON REUTERS

Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data From Phase 1 Proof-of-Concept Trial of Glyphago™ in Healthy Volunteers

THOMSON REUTERS

Seaport Therapeutics - Repeat Dosing of Glyphago Shows Favorable Safety and No Liver-Related Adverse Events

THOMSON REUTERS

Citi Sticks to Its Buy Rating for Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics to Present at Two Major Investor Conferences, Highlighting Neuropsychiatric Drug Development

Seaport Therapeutics to present at Goldman Sachs Global Healthcare Conference

Seaport Therapeutics Initiated at Buy by Stifel

Stifel Initiates Seaport Therapeutics at Buy With $30 Price Target

MT Newswires Live

Seaport Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $30

THOMSON REUTERS

Citigroup Initiates Seaport Therapeutics at Buy With $35 Price Target

MT Newswires Live

Seaport Therapeutics initiated with a Buy at Stifel

Seaport Therapeutics initiated with an Overweight at JPMorgan

Seaport Therapeutics initiated with Early-Stage Biotech at Goldman Sachs

Seaport Therapeutics Inc : JP Morgan Initiates Coverage With Overweight Rating; Price Target $42

THOMSON REUTERS

Seaport Therapeutics files Form 3 as General Atlantic reports 6,101,582 shares

Major Investor Makes Bold New Move on Seaport Therapeutics Stock

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/SPTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","market":"US","secType":"STK","nameCN":"Seaport Therapeutics","latestPrice":23.68,"timestamp":1788206400000,"preClose":24.04,"halted":0,"volume":117842,"hourTrading":{"tag":"盘后","latestPrice":23.68,"preClose":23.68,"latestTime":"16:10 EDT","volume":669,"amount":15841.92,"timestamp":1788207005066,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.014975041597337747,"floatShares":14160000,"shares":53530550,"eps":-2.516,"marketStatus":"Post-Mkt","change":-0.36,"latestTime":"08-31 16:34:01 EDT","open":24.14,"high":26.465,"low":23.0075,"amount":2799754,"amplitude":0.143823,"askPrice":24.6,"askSize":1,"bidPrice":20.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.516,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":24.04,"preHourTrading":{"tag":"盘前","latestPrice":24.52,"preClose":24.04,"latestTime":"08:01 EDT","volume":5,"amount":122.6,"timestamp":1788177713831,"change":0.48,"changeRate":0.019967,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":23.68,"preClose":23.68,"latestTime":"16:10 EDT","volume":669,"amount":15841.92,"timestamp":1788207005066,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.973187},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","floatShares":14160000,"roa":"-18.90%","roe":"-28.08%","lyrEps":-10.043037,"volumeRatio":0.973187,"shares":53530550,"dividePrice":0,"high":26.465,"amplitude":0.143823,"preClose":24.04,"low":23.0075,"week52Low":14.85,"pbRate":"3.00","week52High":28.3833,"institutionHeld":0,"latestPrice":23.68,"committee":0.980198,"eps":-2.516,"divideRate":0,"volume":117842,"delay":0,"ttmEps":-2.516,"open":24.14,"prevYearClose":18,"prevWeekClose":24.04,"prevMonthClose":20.46,"prevQuarterClose":21.72,"fiveDayClose":24.08,"twentyDayClose":20.65,"sixtyDayClose":17.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"SPTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":-1.78}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.4286,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1787716800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPTX","date":"2026-08-28","current":-9.411765,"percent":0.85,"low":-14.505892,"twenty":-12.804736,"median":-12.123719,"eighty":-11.036024,"high":-9.149163,"avg":-11.863013,"sd":1.272196,"marketCap":1405176937},"quantilePoints":[{"date":"2026-05-08","current":-10.976498,"twenty":-12.440976,"median":-11.330579,"eighty":-11.259763,"marketCap":821931163},{"date":"2026-05-15","current":-11.99625,"twenty":-12.004748,"median":-11.348283,"eighty":-11.231436,"marketCap":898291219},{"date":"2026-05-22","current":-12.173291,"twenty":-12.004748,"median":-11.330579,"eighty":-11.135126,"marketCap":911548174},{"date":"2026-05-29","current":-13.31343,"twenty":-12.537286,"median":-11.684659,"eighty":-11.163453,"marketCap":996922959},{"date":"2026-06-05","current":-12.661922,"twenty":-12.698746,"median":-12.017495,"eighty":-11.247016,"marketCap":948137367},{"date":"2026-06-12","current":-12.548616,"twenty":-12.593938,"median":-12.03874,"eighty":-11.316416,"marketCap":939652917},{"date":"2026-06-18","current":-10.501726,"twenty":-12.6166,"median":-12.03874,"eighty":-11.222938,"marketCap":915372405},{"date":"2026-06-26","current":-11.889673,"twenty":-12.53162,"median":-11.895161,"eighty":-11.165224,"marketCap":1036351448},{"date":"2026-07-02","current":-13.173217,"twenty":-12.752567,"median":-12.017495,"eighty":-11.198861,"marketCap":1148230297},{"date":"2026-07-10","current":-12.595929,"twenty":-12.752567,"median":-12.03874,"eighty":-11.215593,"marketCap":1097911580},{"date":"2026-07-17","current":-11.987935,"twenty":-12.752567,"median":-12.12726,"eighty":-11.302253,"marketCap":1044916336},{"date":"2026-07-24","current":-13.474144,"twenty":-12.866109,"median":-12.187454,"eighty":-11.330579,"marketCap":1174460267},{"date":"2026-07-31","current":-12.479243,"twenty":-12.804736,"median":-12.201617,"eighty":-11.330579,"marketCap":1087740776},{"date":"2026-08-07","current":-14.1804,"twenty":-12.896856,"median":-12.347233,"eighty":-11.365987,"marketCap":1236020399},{"date":"2026-08-14","current":-9.423399,"twenty":-12.896856,"median":-12.221306,"eighty":-11.295171,"marketCap":1269209340},{"date":"2026-08-21","current":-9.552568,"twenty":-12.881452,"median":-12.180373,"eighty":-11.146457,"marketCap":1286606769},{"date":"2026-08-28","current":-10.432907,"twenty":-12.804736,"median":-12.123719,"eighty":-11.036024,"marketCap":1405176937}],"updateTime":1788208441651},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641486206","title":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486206","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486206?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:09","pubTimestamp":1780916971,"startTime":"0","endTime":"0","summary":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641864744","title":"Seaport Therapeutics - Q1 Net Loss per Share $10.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2641864744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641864744?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA2FRLJF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641861724","title":"Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2641861724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641861724?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA2FRLJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641609486","title":"Seaport Therapeutics - Seven-Day Glyphago Dosing Achieves Therapeutic Agomelatine Exposures Without Liver Enzyme Elevations","url":"https://stock-news.laohu8.com/highlight/detail?id=2641609486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641609486?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486953","title":"Seaport Therapeutics - to Initiate Phase 2B Glyphago Trial in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486953?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486939","title":"Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data From Phase 1 Proof-of-Concept Trial of Glyphago™ in Healthy Volunteers","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486939?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486675","title":"Seaport Therapeutics - Repeat Dosing of Glyphago Shows Favorable Safety and No Liver-Related Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486675?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640966895","title":"Citi Sticks to Its Buy Rating for Seaport Therapeutics, Inc. (SPTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640966895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640966895?lang=en_us&edition=fundamental","pubTime":"2026-06-02 01:15","pubTimestamp":1780334118,"startTime":"0","endTime":"0","summary":"Citi analyst Yigal Nochomovitz maintained a Buy rating on Seaport Therapeutics, Inc. today and set a price target of $35.00. Nochomovitz covers the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105741779","title":"Seaport Therapeutics to Present at Two Major Investor Conferences, Highlighting Neuropsychiatric Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1105741779","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105741779?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:10","pubTimestamp":1780319430,"startTime":"0","endTime":"0","summary":"Clinical-stage biopharmaceutical company Seaport Therapeutics, which focuses on novel treatments for neuropsychiatric disorders, has announced that its management team will participate in two...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4139","BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640955900","title":"Seaport Therapeutics to present at Goldman Sachs Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640955900","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640955900?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:01","pubTimestamp":1780311677,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics will join the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, featuring an 8:00 a.m. EDT fireside chat.Management will also participate in UBS Virtual CNS Day on June 15, 2026, with a 10:00 a.m. EDT fireside chat.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seaport Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on June 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL53vx61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","LU1894683348.USD","BK4516","LU2265009873.SGD","IE00BFXG1179.USD","IE00BSNM7G36.USD","IE0004091025.USD","BK4007","LU2471134879.HKD","IE00B19Z3B42.SGD","BK4585","BK4588","LU1868837300.USD","LU2471134796.USD","LU2471134523.USD","IE0002270589.USD","LU1791807156.HKD","LU0048573561.USD","LU1894683264.USD","IE0034235188.USD","LU0251142724.SGD","LU1868837136.USD","LU2237438978.USD","LU2237443622.USD","IE0004086264.USD","LU2237443465.HKD","LU2237443978.SGD","LU0868494708.USD","BK4504","LU0345770993.USD","LU0942090050.USD","LU2750360997.AUD","LU0868494617.USD","LU1804176565.USD","LU2237443382.USD","LU0251131958.USD","LU1868836757.USD","SPTX","BK4550","LU0096364046.USD","LU0742534661.SGD","LU1668664300.SGD","LU2471134952.CNY","BK4552","LU2237443549.SGD","LU2750360641.GBP","LU1868836914.USD","GSX","BK4127","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638954607","title":"Seaport Therapeutics Initiated at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2638954607","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638954607?lang=en_us&edition=fundamental","pubTime":"2026-05-27 00:11","pubTimestamp":1779811860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 26, 2026 12:11 ET (16:11 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX","BK4007","BK4127","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511679","title":"Stifel Initiates Seaport Therapeutics at Buy With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511679","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511679?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:47","pubTimestamp":1779796045,"startTime":"0","endTime":"0","summary":"(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638515068","title":"Seaport Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2638515068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638515068?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:46","pubTimestamp":1779792377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN42306X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638669515","title":"Citigroup Initiates Seaport Therapeutics at Buy With $35 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638669515","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638669515?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:33","pubTimestamp":1779791609,"startTime":"0","endTime":"0","summary":"Citigroup Initiates Seaport Therapeutics at Buy With $35 Price Target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638599590","title":"Seaport Therapeutics initiated with a Buy at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2638599590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638599590?lang=en_us&edition=fundamental","pubTime":"2026-05-26 17:16","pubTimestamp":1779786975,"startTime":"0","endTime":"0","summary":"Stifel initiated coverage of Seaport Therapeutics (SPTX) with a Buy rating and $30 price target The firm says the company offers “two compelling sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","SF","BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638590565","title":"Seaport Therapeutics initiated with an Overweight at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2638590565","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638590565?lang=en_us&edition=fundamental","pubTime":"2026-05-26 17:05","pubTimestamp":1779786305,"startTime":"0","endTime":"0","summary":"JPMorgan initiated coverage of Seaport Therapeutics (SPTX) with an Overweight rating and $42 price target The company is using its Glyph platform, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638559218","title":"Seaport Therapeutics initiated with Early-Stage Biotech at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2638559218","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638559218?lang=en_us&edition=fundamental","pubTime":"2026-05-26 16:25","pubTimestamp":1779783942,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Salveen initiated coverage of Seaport Therapeutics (SPTX) with an Early-Stage Biotech rating and no price target The company ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-initiated-with-early-stage-biotech-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-initiated-with-early-stage-biotech-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0345770308.USD","BK4585","LU1668664300.SGD","LU1868837300.USD","SPTX","IE0004086264.USD","IE0002270589.USD","IE0004091025.USD","BK4552","LU2237443895.HKD","LU0061475181.USD","LU1868836591.USD","SSI","BK4504","LU1791807156.HKD","BK4007","LU2471134952.CNY","LU2750360997.AUD","BK4581","IE00BFXG1179.USD","LU1894683348.USD","BK4127","LU2237438978.USD","XBI","LU1804176565.USD","LU0742534661.SGD","LU1868837136.USD","LU2237443382.USD","LU0048573561.USD","LU2265009873.SGD","LU0106831901.USD","IE00B19Z3581.USD","LU1868836757.USD","LU2237443622.USD","LU2471134796.USD","BK4516","LU1894683264.USD","LU2237443549.SGD","LU0942090050.USD","LU0868494708.USD","LU2237443465.HKD","LU2471134879.HKD","LU2471134523.USD","LU0868494617.USD","IE00B19Z3B42.SGD","LU1868836914.USD","BK4550","GSX","BK4533","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638560240","title":"Seaport Therapeutics Inc : JP Morgan Initiates Coverage With Overweight Rating; Price Target $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2638560240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638560240?lang=en_us&edition=fundamental","pubTime":"2026-05-26 12:48","pubTimestamp":1779770937,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN422025:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633727164","title":"Seaport Therapeutics files Form 3 as General Atlantic reports 6,101,582 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2633727164","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633727164?lang=en_us&edition=fundamental","pubTime":"2026-05-07 09:15","pubTimestamp":1778116533,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics  Form 3 filing shows General Atlantic  reporting indirect beneficial ownership of 6,101,582 shares of Common Stock.Filing lists reporting group as director, 10% owner; date of event requiring statement May 4, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seaport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL1b7z65:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633699332","title":"Major Investor Makes Bold New Move on Seaport Therapeutics Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2633699332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633699332?lang=en_us&edition=fundamental","pubTime":"2026-05-05 10:08","pubTimestamp":1777946888,"startTime":"0","endTime":"0","summary":"New insider activity at Seaport Therapeutics, Inc. ( ($SPTX) ) has taken place on May 4, 2026. ARCH Venture Partners XII, LLC, a significant shareh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-new-move-on-seaport-therapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-new-move-on-seaport-therapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":46,"code":"91000000","status":"200"}]}}